NeuExcell Therapeutics’ $15 Million Series Pre-A+ Financing Round

Martina Bellini
Tagged:

Cooley advised NeuExcell Therapeutics on the deal.NeuExcell Therapeutics, a neurodegenerative disease gene therapy company, announced its $15 million+ Series Pre-A+ financing round. Investors in the round included…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now